aditxt.com (ADTX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Aditxt is fighting a tough battle for market position, attempting to balance the launch of immunotherapy with a heavy debt burden. The linear price action on the chart, where the EV/EBITDA ratio stands at 0.00, links these challenges to expansion through the acquisition of fintech and biotech assets to create product synergies. Meanwhile, the business relies on sustained interest in personalized medicine, which mitigates its moderate dependence on economic cycles.
aditxt.com - analytical breakdowns and key metrics (ADTX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ADTX - Net Financial Result|Future Profit Aditxt|ADTX - Market Price to Net Income Ratio|Projected Price to Earnings Aditxt, Inc.|ADTX - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio Aditxt, Inc.|ADTX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Aditxt|ADTX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth aditxt.com|ADTX - Earnings per share growth this year|Expected earnings per share growth for next year Aditxt
Initial company analysis:Aditxt Corp ADTX
Aditxt (ADTX) maintains its market share through complex certifications and unique patents in the field of immunity monitoring. The EV/EBITDA metric compares the total enterprise value, including debt, to operating profit, measuring the company's ability to service its obligations using core income. Investors should assess the asset's resilience to shocks by analyzing the volatility of the current valuation based on the EV/EBITDA multiple.
Competitors of Aditxt
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc (PGEN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PHAR (Pharming)|Enterprise Value to Operating Income Before Depreciation Ratio NKTR|Upstream Bio Inc - Enterprise Value to EBITDA Ratio|ZBIO: Enterprise Value to Operating Income Before Depreciation|IMNM: Enterprise Value to EBITDA Ratio|Gossamer Bio Inc - Enterprise Value to Operating Income Before Depreciation Ratio|KALV: EV/EBITDA Multiple|Septerna Pharma (SEPN) - EV/EBITDA Multiple|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation SVRA (savarapharma.com)|Enterprise Value to EBITDA Ratio RIGL (Rigel Pharmaceuticals, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio ANAB|Astria Pharma - Enterprise Value to EBITDA Ratio|ENGN: Enterprise Value to Operating Income Before Depreciation|RAPT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio JBIO|ACRS: EV/EBITDA Multiple|Kyverna Therapeutics Inc. - Business Value to Operating Income Before Depreciation|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|EV/EBITDA Multiple Cabaletta Bio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|THTX (theratech.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN - Enterprise Value to EBITDA Ratio|Agenus Inc - EV/EBITDA Multiple|CLYM - EV/EBITDA Multiple|ZURA (Zura Bio) - Enterprise Value to EBITDA Ratio|atyrpharma.com - Business Value to Operating Income Before Depreciation|ADAG (Adagene Inc) - EV/EBITDA Multiple|Ikena Oncology, Inc. (IMA) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Labs, Inc. (STTK)|Enterprise Value to EBITDA Ratio equilliumbio.com EQ|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|IMUX - Enterprise Value to EBITDA Ratio|ATRA: Enterprise Value to EBITDA Ratio|IFRX - EV/EBITDA Multiple|X4 Pharma (XFOR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ACET|CELU (Celularity Inc) - EV/EBITDA Multiple|Company Value to EBITDA inmunebio.com INMB|EV/EBITDA Multiple BRNS|EV/EBITDA Multiple Kezar Life Sciences Inc. (KZR)|EV/EBITDA Multiple SABS (SAB Biotherapeutics, Inc)|AKTX: Enterprise Value to Operating Income Before Depreciation|Enlivex Therapeutics, Ltd. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Q32 Bio Inc. QTTB|GOVX (GeoVax) - Enterprise Value to EBITDA Ratio|EDSA: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio IBIO|Enterprise Value to Operating Income Before Depreciation CARM (Carisma Tx)|Enterprise Value to EBITDA Ratio XTLB (XTL Biopharmaceuticals)|Enterprise Value to Operating Income Before Depreciation Ratio BOLT|EV/EBITDA Multiple HCWB (HCW Biologics)|EV/EBITDA Multiple Aptevo Therapeutics, Inc. APVO|AIM ImmunoTech Inc. - EV/EBITDA Multiple|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|HIND: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio REVB|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|CALI: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AFMD (Affimed N.V.)|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
